Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betul Oran

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Blood|August 23, 2014
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHDIssa F Khouri, Wei Wei, Martin Korbling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic SyndromesMarcos de Lima, Betul Oran, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2017
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation OutcomesGabriela Rondón, Rima M Saliba, Julianne Chen, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Blood|August 23, 2014
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHDIssa F Khouri, Wei Wei, Martin Korbling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic SyndromesMarcos de Lima, Betul Oran, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2017
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation OutcomesGabriela Rondón, Rima M Saliba, Julianne Chen, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Cytotherapy|March 4, 2014
Low rate of infusional toxicity after expanded cord blood transplantationAdham S Bear, Patrick J Hanley, Doyle M Bosque, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Pageof 15